MoneyWorks4Me

NGL Fine-Chern informs about conference call

04 Jun 2021 Evaluate

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NGL Fine-Chern has informed that the Company will hold a Conference Call with Investors, on Thursday, 10th June, 2021 at 11.30 am to discuss the Q4 & Audited Financial Results of the Company for the year ended 31st March, 2021 and to discuss business outlook. No price sensitive information will be disclosed or discussed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..